Perrigo Co PLC (PRGO)
30.48
+0.42
(+1.40%)
USD |
NYSE |
Apr 23, 16:00
30.48
0.00 (0.00%)
After-Hours: 20:00
Perrigo Enterprise Value: 7.396B for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 7.396B |
| April 19, 2024 | 7.496B |
| April 18, 2024 | 7.379B |
| April 17, 2024 | 7.393B |
| April 16, 2024 | 7.382B |
| April 15, 2024 | 7.405B |
| April 12, 2024 | 7.431B |
| April 11, 2024 | 7.561B |
| April 10, 2024 | 7.596B |
| April 09, 2024 | 7.688B |
| April 08, 2024 | 7.625B |
| April 05, 2024 | 7.577B |
| April 04, 2024 | 7.584B |
| April 03, 2024 | 7.527B |
| April 02, 2024 | 7.566B |
| April 01, 2024 | 7.674B |
| March 28, 2024 | 7.684B |
| March 27, 2024 | 7.585B |
| March 26, 2024 | 7.496B |
| March 25, 2024 | 7.524B |
| March 22, 2024 | 7.566B |
| March 21, 2024 | 7.602B |
| March 20, 2024 | 7.564B |
| March 19, 2024 | 7.420B |
| March 18, 2024 | 7.389B |
| Date | Value |
|---|---|
| March 15, 2024 | 7.438B |
| March 14, 2024 | 7.505B |
| March 13, 2024 | 7.526B |
| March 12, 2024 | 7.462B |
| March 11, 2024 | 7.468B |
| March 08, 2024 | 7.421B |
| March 07, 2024 | 7.346B |
| March 06, 2024 | 7.129B |
| March 05, 2024 | 7.016B |
| March 04, 2024 | 6.877B |
| March 01, 2024 | 6.890B |
| February 29, 2024 | 6.881B |
| February 28, 2024 | 6.901B |
| February 27, 2024 | 7.022B |
| February 26, 2024 | 7.682B |
| February 23, 2024 | 7.679B |
| February 22, 2024 | 7.633B |
| February 21, 2024 | 7.658B |
| February 20, 2024 | 7.702B |
| February 16, 2024 | 7.662B |
| February 15, 2024 | 7.707B |
| February 14, 2024 | 7.599B |
| February 13, 2024 | 7.626B |
| February 12, 2024 | 7.713B |
| February 09, 2024 | 7.642B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.882B
Minimum
May 09 2022
11.29B
Maximum
Feb 25 2020
8.601B
Average
8.659B
Median
Enterprise Value Benchmarks
| Alkermes PLC | 3.537B |
| Endo International PLC | -777.75M |
| Jazz Pharmaceuticals PLC | 10.87B |
| Medtronic PLC | 123.99B |
| Iterum Therapeutics PLC | 20.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.30M |
| Revenue (Quarterly) | 1.157B |
| Total Expenses (Quarterly) | 1.066B |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | 36.93% |
| Profit Margin (Quarterly) | -2.79% |
| Earnings Yield | -0.33% |
| Operating Earnings Yield | 6.85% |
| Normalized Earnings Yield | 2.334 |